PerkinElmer Q1 revenues edge up, profit edges down

By The Science Advisory Board staff writers

May 8, 2020 -- In financial results for the first quarter, PerkinElmer saw revenues grow slightly, but net income slipped.

For the period, PerkinElmer recorded revenues of $652.4 million, up 1% compared to revenue of $648.7 million in the first quarter of 2019. The company's net income fell slightly, to $33.7 million, compared with $35.4 million in the corresponding quarter the year before.

In the company's diagnostics business, revenue was $254 million, compared to $259.9 million in the first quarter of 2019. Operating income from continuing operations in the business was $29.6 million, versus $31.5 million the same period the year before.

PerkinElmer executives said the company delivered "a very good quarter" despite macroeconomic uncertainty. At the same time, in releasing the financial results, PerkinElmer withdrew its previously issued financial guidance for the rest of the year.

The company also announced that its SARS-CoV-2 enzyme-linked immunosorbent assay (ELISA) for immunoglobulin G (IgG) antibodies has been granted emergency use authorization by the U.S. Food and Drug Administration (FDA). The test is ready for use by labs that are CLIA-certified to perform high complexity testing, the company said.

PerkinElmer launches new workflow tools
PerkinElmer has released a variety of new tools to help pharmaceutical, semiconductor, biomonitoring, and food and material labs improve their testing...
Shortage of RNA extraction kits threatens coronavirus testing
The weak link in the U.S. response to diagnostic testing for the novel coronavirus SARS-CoV-2 could be a shortage of RNA extraction kits. Fortunately,...

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands
Bioprocess International West
August 10-13
Santa Clara, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter